Lars B. Abrahmsen Aprea Therapeutics, Inc. (APRE) insider trading activity

APRE Quotes by TradingView

Lars B. Abrahmsen is SVP, Chief Scientific Officer of Aprea Therapeutics, Inc.. Currently has a direct ownership of 43,700 shares of APRE, which is worth approximately $111,434. The most recent transaction as insider was on Mar 10, 2022, when has been sold 24,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.7K
0% 3M change
0% 12M change
Total Value Held $111,434

Lars B. Abrahmsen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2022
BUY
Grant, award, or other acquisition
-
24,700 Added 36.11%
43,700 Common Stock
Oct 01 2021
SELL
Open market or private sale
$244,500 $4.89 p/Share
50,000 Reduced 72.46%
19,000 Common Stock
Oct 01 2021
BUY
Exercise of conversion of derivative security
$46,000 $0.92 p/Share
50,000 Added 42.02%
69,000 Common Stock
Sep 20 2021
SELL
Open market or private sale
$124,250 $4.97 p/Share
25,000 Reduced 56.82%
19,000 Common Stock
Sep 20 2021
BUY
Exercise of conversion of derivative security
$23,000 $0.92 p/Share
25,000 Added 36.23%
44,000 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
19,000 Added 50.0%
19,000 Common Stock
LBA

Lars B. Abrahmsen

SVP, Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

News

Receive news related to Aprea Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APRE